Answers are grounded in this paper and cite their sources.
Viewpoint discusses the role of AI in clinical decision support for diagnostics and treatment planning, highlighting governance needs.
Unlabelled: Medical AI agents are emerging as a new generation of clinical decision support systems, moving beyond static prediction toward multistep, workflow-oriented assistance. This Viewpoint argues that agentic architectures incorporating planning, action, reflection, and memory (PARM) represent a meaningful evolution beyond traditional rule-based, machine learning, and multimodal clinical decision support systems. Using PARM as an analytical lens, we examine how medical AI agents can support diagnostic reasoning, treatment planning, and longitudinal monitoring while remaining constrained by human oversight. We further discuss the governance mechanisms required for responsible implementation, including bounded autonomy, auditability, verification protocols, postdeployment surveillance, and clear accountability structures. Rather than proposing autonomous modification of clinical judgment, this Viewpoint emphasizes agentic AI as a supervised workflow support paradigm. Safe implementation will require technical safeguards, institutional governance, regulatory clarity, and evaluation approaches that assess end-to-end task reliability, escalation behavior, and performance under deployment shifts.
No takes yet. Share an insight, caveat, or question.
Dinç et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: